Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
BioIVT will be hosting a webinar entitled “Whole-cell In Vitro Models Can Predict Clinically-relevant Herb-Drug Interactions (HDIs)” at 11 am ET on June 20. Read More
Asymmetrex founder and director James Sherley addresses the importance and challenges of introducing stem cell dose standardization into regenerative medicine practice. Read More
Landos Biopharma presents findings for its lead candidate, BT-11, at Digestive Disease Week Read More
Stem cell biotechnology company Asymmetrex and preclinical toxicology CRO DRIK have formed a new partnership for addressing a significant unmet need in the pharmaceutical and cell therapy industries. Read More
Partnership to define the new market paradigm of digital therapeutics and to create clinical decision support tools by incentivizing early stage health technology developers. Read More